In this issue:
NAFLD may be a modifiable risk factor for young-onset ovarian cancer
SOLO3: OS results for olaparib vs nonplatinum chemo for relapsed disease
Risk factors for anastomotic leakage
Final survival data from the NOVA niraparib maintenance trial
Real-world effectiveness of MIRV
Bevacizumab re-treatment beneficial after EOC progression
Better survival with interval vs delayed cytoreduction in advanced disease
Prognosis of subtypes of stage I ovarian mucinous tumours
Is primary vs interval cytoreductive surgery better for metastatic disease?
HIPEC at upfront surgery improves longterm survival in Stage 3 EOC
Expert contributor
Dr Rhett Morton is a sub-specialist Gynaecological Oncologist based in Brisbane at the Mater public and Wesley private hospitals. He is a senior lecturer at University of Queensland Centre for Clinical Research and has interests in regional and global health equity, surgical training and observational research methodology.
Stay up to date with our latest clinical information.
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.